eventscribe

The eventScribe Educational Program Planner system gives you access to information on sessions, special events, and the conference venue. Take a look at hotel maps to familiarize yourself with the venue, read biographies of our plenary speakers, and download handouts and resources for your sessions.

close this panel

SUBMIT FEEDBACKfeedback icon

Comments


close this panel
support

Technical Support


Phone: (410) 638-9239

Fax: (410) 638-6108

GoToMeeting: Meet Now!

Web: www.CadmiumCD.com

Submit Support Ticket

t on the system-->

close this panel
‹‹ Go Back

Hui Quan

Sanofi



‹‹ Go Back

Bingzhi Zhang

Sanofi



‹‹ Go Back

Christy Chuang-Stein



‹‹ Go Back

Byron Jones

Novartis



�� Go Back

Please enter your access key

The asset you are trying to access is locked for premium users. Please enter your access key to unlock.


Email This Presentation:

From:

To:

Subject:

Body:

←Back IconGems-Print

88 – Topics in Clinical Trials 2

Integrated Data Analysis for Assessing Treatment Effect Through Combining Information

Sponsor: Biopharmaceutical Section
Keywords: meta-analysis, historical data, surrogate endpoint, sample size calculation

Hui Quan

Sanofi

Bingzhi Zhang

Sanofi

Christy Chuang-Stein

Byron Jones

Novartis

It is critical to use a precise estimate of treatment effect when drawing conclusions, evaluating benefit/risk or designing a new study. Utilization of data from all sources in an integrated data analysis/meta-analysis will help us move closer to meeting this need. Depending on the data sources and objectives, there are many approaches for integrated analyses. These include network meta-analysis, multivariate meta-analysis, model-based meta-analysis as well as methods of borrowing historical data. In this paper, we discuss these methods with additional details for implementation and interpretation. We consider information adaptive repeated cumulative meta-analyses. We also discuss how to apply three integrated analysis approaches that take into account the variability of the overall treatment effect estimate to determine sample size for a new trial. Some computation and simulation results are provided.

"eventScribe", the eventScribe logo, "CadmiumCD", and the CadmiumCD logo are trademarks of CadmiumCD LLC, and may not be copied, imitated or used, in whole or in part, without prior written permission from CadmiumCD. The appearance of these proceedings, customized graphics that are unique to these proceedings, and customized scripts are the service mark, trademark and/or trade dress of CadmiumCD and may not be copied, imitated or used, in whole or in part, without prior written notification. All other trademarks, slogans, company names or logos are the property of their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, owner, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by CadmiumCD.

As a user you may provide CadmiumCD with feedback. Any ideas or suggestions you provide through any feedback mechanisms on these proceedings may be used by CadmiumCD, at our sole discretion, including future modifications to the eventScribe product. You hereby grant to CadmiumCD and our assigns a perpetual, worldwide, fully transferable, sublicensable, irrevocable, royalty free license to use, reproduce, modify, create derivative works from, distribute, and display the feedback in any manner and for any purpose.

© 2015 CadmiumCD